Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-09-15 Sale | 2021-09-17 4:27 pm | Sana Biotechnology Inc. | SANA | AGARWAL SUNIL EVP, Head of Development & CMO | 60,000 | $26.07 | $1,564,057 | 1,550,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-06-25 Option Award | 2025-06-30 06:14 am | N/A 2035-06-24 | ARVINAS INC. | ARVN | AGARWAL SUNIL Director | 39,130 | $0 | 53,271 (Direct) | View |
2025-06-11 Option Award | 2025-06-12 7:16 pm | N/A 2035-06-10 | Astria Therapeutics Inc. | ATXS | AGARWAL SUNIL Director | 26,550 | $0 | 26,550 (Direct) | View |
2024-05-29 Option Award | 2024-05-31 5:52 pm | N/A 2034-05-28 | ARVINAS INC. | ARVN | AGARWAL SUNIL Director | 14,969 | $0 | 23,211 (Direct) | View |
2024-04-08 Option Award | 2024-04-09 08:11 am | N/A 2034-04-07 | Astria Therapeutics Inc. | ATXS | AGARWAL SUNIL Director | 28,200 | $0 | 28,200 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 5:25 pm | N/A 2033-06-14 | ARVINAS INC. | ARVN | AGARWAL SUNIL Director | 33,190 | $0 | 33,190 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 4:05 pm | N/A 2032-05-31 | Calithera Biosciences Inc. | CALA | AGARWAL SUNIL Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-03-03 Option Award | 2022-03-08 09:07 am | N/A 2032-03-02 | Sana Biotechnology Inc. | SANA | AGARWAL SUNIL EVP, Head of Development & CMO | 250,000 | $0 | 250,000 (Direct) | View |
2021-06-11 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | Calithera Biosciences Inc. | CALA | AGARWAL SUNIL Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-02-03 Option Award(A) | 2021-02-18 6:50 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks | 76,682 | $0 | 76,682 (Direct) | View |
2021-02-03 Option Award | 2021-02-05 5:20 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
Ownership | 2021-02-03 9:47 pm | N/A N/A | Sana Biotechnology Inc. | SANA | AGARWAL SUNIL See Remarks | 0 | $0 | 1,810,000 (Direct) | View |
2020-11-17 Equity Swap | 2020-11-19 8:20 pm | N/A N/A | MyoKardia Inc. | MYOK | AGARWAL SUNIL Director | 4,100 | $0 | 0 (Direct) | View |